Immunogen Enterprise Value:
1.062B for April 24, 2018Immunogen Enterprise Value Chart
Immunogen Historical Enterprise Value Data
| Data for this Date Range | |
|---|---|
| April 24, 2018 | 1.062B |
| April 23, 2018 | 1.079B |
| April 20, 2018 | 1.099B |
| April 19, 2018 | 1.095B |
| April 18, 2018 | 1.089B |
| April 17, 2018 | 1.154B |
| April 16, 2018 | 1.106B |
| April 13, 2018 | 1.077B |
| April 12, 2018 | 1.127B |
| April 11, 2018 | 1.087B |
| April 10, 2018 | 1.093B |
| April 9, 2018 | 1.047B |
| April 6, 2018 | 1.062B |
| April 5, 2018 | 1.106B |
| April 4, 2018 | 1.171B |
| April 3, 2018 | 1.117B |
| April 2, 2018 | 1.089B |
| March 29, 2018 | 1.132B |
| March 28, 2018 | 1.162B |
| March 27, 2018 | 1.198B |
| March 26, 2018 | 1.455B |
| March 23, 2018 | 1.342B |
| March 22, 2018 | 1.350B |
| March 21, 2018 | 1.396B |
| March 20, 2018 | 1.372B |
| March 19, 2018 | 1.332B |
| March 16, 2018 | 1.358B |
| March 15, 2018 | 1.307B |
| March 14, 2018 | 1.273B |
| March 13, 2018 | 1.316B |
| March 12, 2018 | 1.276B |
| March 9, 2018 | 1.228B |
| March 8, 2018 | 1.168B |
| March 7, 2018 | 1.283B |
| March 6, 2018 | 1.240B |
| March 5, 2018 | 1.260B |
| March 2, 2018 | 1.239B |
| March 1, 2018 | 1.198B |
| Feb. 28, 2018 | 1.211B |
| Feb. 27, 2018 | 1.182B |
| Feb. 26, 2018 | 1.193B |
| Feb. 23, 2018 | 1.218B |
| Feb. 22, 2018 | 1.174B |
| Feb. 21, 2018 | 1.283B |
| Feb. 20, 2018 | 1.226B |
| Feb. 16, 2018 | 1.229B |
| Feb. 15, 2018 | 1.146B |
| Feb. 14, 2018 | 1.080B |
| Feb. 13, 2018 | 1.034B |
| Feb. 12, 2018 | 1.132B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
IMGN Enterprise Value Benchmarks
| Benchmarks | |
|---|---|
| Intercept Pharmaceuticals | 1.877B |
| Alnylam Pharmaceuticals | 7.829B |
| PTC Therapeutics | 1.058B |
IMGN Enterprise Value Range, Past 5 Years
| Minimum | 36.98M | Dec 21 2016 |
| Maximum | 1.472B | Jul 12 2013 |
| Average | 708.99M |
IMGN Enterprise Value Excel Add-In Codes
- Metric Code: enterprise_value
- Latest data point: =YCP("IMGN", "enterprise_value")
- Last 5 data points: =YCS("IMGN", "enterprise_value", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
IMGN News
Business Wire 04/25 08:00 ET
Business Wire 04/20 08:00 ET
